Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2026 –2033 | |
|
|
USD 795.22 Million |
| USD 874.84 Million | |
| % | |
|
Europe Angioplasty Balloons Market Segmentation, By Type (Plain Old Balloon Angioplasty, Drug-Coated Balloon (DCB) Angioplasty, Cutting Balloons, Scoring Balloons, and Stent Graft Balloon Catheter), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, and Other), Balloon Type (Semi-Compliant and Non-Compliant), Disease Indication (Coronary Angioplasty, Venous Angioplasty, Carotid Angioplasty, Renal Artery Angioplasty, and Peripheral Angioplasty), End User (Cath Labs, Hospitals, Specialty Clinics, Ambulatory Surgery Centers, and Diagnostic Centers)- Industry Trends and Forecast to 2033
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
Europe Angioplasty Balloons Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
Europe
|
|
Key Market Players
|
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
“Innovation in Drug-Coated and Specialty Balloons”
Driver
“Rising Cardiovascular Disease Prevalence and Minimally Invasive Preference”
Restraint/Challenge
“Cost and Regulatory Compliance Hurdles”
The market is segmented on the basis of type, material, balloon type, disease indication, and end user.
On the basis of type, the Europe angioplasty balloons market is segmented into Plain Old Balloon Angioplasty (POBA), Drug-Coated Balloon (DCB) Angioplasty, Cutting Balloons, Scoring Balloons, and Stent Graft Balloon Catheter. The Drug-Coated Balloon (DCB) segment dominated the market with the largest revenue share of 47.8% in 2025, driven by its proven efficacy in reducing restenosis, growing clinical adoption, and suitability for complex coronary and peripheral interventions. Interventional cardiologists often prefer DCBs for high-risk patients, as they deliver localized drugs to the arterial walls without leaving permanent implants. The segment also benefits from innovations in coating technologies and delivery systems that enhance procedural precision. Hospitals and cath labs in Germany, France, and the U.K. routinely utilize DCBs, reinforcing their dominant market position. Increasing clinical evidence supporting long-term patient outcomes further accelerates adoption. In addition, partnerships between manufacturers and healthcare institutions promote awareness and training, sustaining segment leadership.
The Cutting Balloon segment is anticipated to witness the fastest growth from 2026 to 2033, fueled by rising adoption in complex lesion treatments, including calcified and fibrotic plaques. Cutting balloons provide controlled scoring of the plaque, improving lumen gain and procedural outcomes while reducing trauma to arterial walls. They are increasingly adopted in specialty clinics and tertiary cardiac centers due to precision and safety. Clinical trials demonstrating enhanced outcomes in challenging lesions further support market expansion. Rising prevalence of cardiovascular diseases and aging populations are driving demand for cutting balloons across Europe. Manufacturers are focusing on next-generation cutting balloons with improved deliverability and safety profiles, ensuring continued growth.
On the basis of material, the market is segmented into nylon, polyurethane, silicone urethane co-polymers, and others. The Nylon segment dominated the market in 2025, owing to its excellent flexibility, trackability, and compatibility with complex catheter navigation. Nylon balloons are highly favored by interventional cardiologists for tortuous and calcified vessels, offering reliable performance across coronary and peripheral procedures. Their cost-effectiveness and wide availability make them suitable for most hospitals. They also exhibit good expansion control, reducing procedural complications. Continuous R&D has enhanced material durability and safety, further reinforcing dominance. Adoption is particularly high in Germany and France, where advanced cardiac centers rely on Nylon-based balloons for routine and complex interventions.
The Silicone Urethane Co-Polymers segment is expected to witness the fastest growth from 2026 to 2033, driven by superior compliance, enhanced drug coating adherence, and improved safety profiles. This material allows precise arterial expansion while minimizing vessel trauma, making it ideal for DCBs and specialty balloons. The demand is rising in hospitals and specialty clinics seeking advanced solutions for high-risk patients. Innovation in polymer formulations is improving procedural outcomes and reducing complications. Growing awareness of safety and long-term efficacy is boosting adoption across Europe. Manufacturers are actively promoting the advantages of this material to expand its clinical usage.
On the basis of balloon type, the market is segmented into semi-compliant and non-compliant balloons. The Semi-Compliant segment dominated the market in 2025, as these balloons provide an optimal balance between flexibility and vessel expansion control, suitable for a wide range of coronary and peripheral interventions. They conform to varying vessel diameters and navigate tortuous anatomies, reducing procedural complications. Compatibility with DCBs, scoring, and cutting balloons further enhances clinical adoption. Hospitals and cath labs prefer semi-compliant balloons for routine interventions. Continuous innovation in catheter and balloon design strengthens their clinical utility. Their wide availability and cost-effectiveness support ongoing dominance.
The Non-Compliant segment is expected to witness the fastest growth from 2026 to 2033, driven by its precision in high-pressure applications and use in post-dilation of stented arteries. Non-compliant balloons are critical in complex lesions where controlled dilation is necessary to avoid vessel rupture. Their adoption is increasing in tertiary cardiac centers performing advanced interventions. Improved material technology and safety features further boost market growth. Rising awareness of procedural precision among cardiologists accelerates demand. Manufacturers are investing in next-generation non-compliant balloons with enhanced deliverability and trackability.
On the basis of disease indication, the market is segmented into coronary angioplasty, venous angioplasty, carotid angioplasty, renal artery angioplasty, and peripheral angioplasty. The Coronary Angioplasty segment dominated the market in 2025, accounting for the majority of procedures due to high prevalence of coronary artery disease in Europe. Coronary interventions are routinely performed in hospitals and specialized cath labs, with drug-coated and specialty balloons well established. Technological innovation, reimbursement support, and improved patient outcomes reinforce the segment’s leadership. Increasing numbers of elderly patients drive procedure volumes. Clinical guidelines continue to promote minimally invasive coronary interventions. Leading manufacturers focus on product portfolios tailored for coronary procedures, sustaining dominance.
The Peripheral Angioplasty segment is expected to witness the fastest growth from 2026 to 2033, driven by increasing incidence of peripheral artery disease, especially in the elderly. Peripheral interventions require specialized balloons, including drug-coated and scoring types, for complex lesions in leg and arm arteries. Growing awareness among physicians and patients, combined with adoption of minimally invasive techniques, accelerates market growth. Manufacturers are introducing advanced peripheral balloons with better safety and trackability. Expanding infrastructure in specialty clinics and hospitals supports adoption. Rising focus on patient comfort and reduced hospital stays further drives demand.
On the basis of end user, the market is segmented into cath labs, hospitals, specialty clinics, ambulatory surgery centers, and diagnostic centers. The Hospitals segment dominated the market in 2025, due to large procedure volumes, advanced infrastructure, and presence of experienced interventional cardiologists. Hospitals perform complex coronary and peripheral interventions and invest heavily in DCBs, scoring, and cutting balloons. High patient footfall, routine adoption of innovative procedures, and established cardiac programs contribute to the leading market share. Continuous training and clinical education strengthen procedural outcomes. Hospitals also leverage advanced imaging and delivery systems, reinforcing dominance.
The Specialty Clinics segment is expected to witness the fastest growth from 2026 to 2033, as smaller clinics increasingly adopt minimally invasive interventions for targeted populations. Specialty clinics expand infrastructure for peripheral and coronary interventions with high-precision, patient-specific balloon therapies. Rising cardiovascular awareness, procedural efficiency, and cost-effective care models are driving rapid adoption. Clinics are investing in DCBs and cutting/scoring balloons for niche patient needs. Training programs and partnerships with manufacturers support clinical expertise. Growing patient preference for outpatient and day-care interventions further fuels growth.
The Germany Angioplasty Balloons Market Insight
The Germany angioplasty balloons market captured the largest revenue share of 28.4% in 2025, driven by well-established healthcare infrastructure, high procedural volumes, and the presence of leading interventional cardiology device manufacturers. Hospitals and specialized cath labs prioritize the use of advanced balloon technologies, including drug-coated, cutting, and scoring balloons, for complex coronary and peripheral interventions. The country’s strong focus on minimally invasive procedures and ongoing clinical training programs supports widespread adoption. Moreover, reimbursement policies and public health initiatives promote the use of innovative balloons across hospitals and cardiac centers. Continuous investment in research and development, along with partnerships between manufacturers and healthcare providers, is further propelling market expansion. Germany’s emphasis on patient safety and procedural efficiency ensures sustained demand for angioplasty balloons across the region.
France Angioplasty Balloons Market Insight
The France angioplasty balloons market anticipated to grow at a noteworthy CAGR in 2025, fueled by growing cardiovascular disease prevalence and increasing awareness among healthcare providers. Hospitals and specialty cardiac centers are adopting advanced balloon technologies, including drug-coated and semi-compliant balloons, for both coronary and peripheral interventions. France’s investment in healthcare infrastructure and training programs enhances procedural efficiency and adoption rates. Increasing focus on minimally invasive therapies, patient safety, and long-term outcomes supports market growth. In addition, favorable reimbursement policies encourage the use of high-precision balloons in complex cases. Collaborations between manufacturers and medical institutions are also promoting clinical education and procedural adoption.
U.K. Angioplasty Balloons Market Insight
The U.K. angioplasty balloons market held a 15% revenue share in 2025, driven by well-developed cardiac care programs, high procedural volumes, and growing adoption of minimally invasive interventions. Hospitals and cath labs increasingly utilize drug-coated and cutting/scoring balloons to improve patient outcomes and reduce restenosis. Rising awareness of cardiovascular diseases among patients and clinicians contributes to the strong demand for advanced balloon technologies. The country’s robust healthcare infrastructure, along with ongoing clinical trials and physician training, supports procedural precision. In addition, adoption in both public and private hospitals ensures widespread usage. Manufacturers are actively promoting advanced balloon devices, which further enhances market growth in the U.K.
Italy Angioplasty Balloons Market Insight
The Italy angioplasty balloons market contributed 8% of Europe’s market in 2025, driven by expanding healthcare infrastructure and growing prevalence of coronary and peripheral artery diseases. Hospitals and cardiac centers are increasingly using drug-coated, semi-compliant, and specialty balloons for minimally invasive interventions. The focus on improving procedural success and reducing patient recovery time supports adoption. Clinical awareness programs and training initiatives for interventional cardiologists are enhancing usage across hospitals. Favorable reimbursement schemes for coronary and peripheral procedures are also encouraging hospitals to invest in advanced balloon technologies. Collaboration with manufacturers ensures ongoing supply of innovative devices, boosting market penetration.
The Europe Angioplasty Balloons industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.